Brivudine(Synonyms: 溴夫定; Bromovinyldeoxyuridine; BVDU)

发表于由

Brivudine (Synonyms: 溴夫定; Bromovinyldeoxyuridine; BVDU)

Brivudine是具有抗病毒活性的胸苷类似物,用于早期急性带状疱疹的研究。

Brivudine(Synonyms: 溴夫定; Bromovinyldeoxyuridine; BVDU)

Brivudine Chemical Structure

CAS No. : 69304-47-8

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
10 mM * 1 mL in DMSO ￥500 In-stock
25 mg ￥450 In-stock
50 mg ￥650 In-stock
100 mg ￥750 In-stock
200 mg ￥1200 In-stock
500 mg   询价  
1 g   询价  

* Please select Quantity before adding items.

Brivudine 相关产品

•相关化合物库:

  • Covalent Screening Library Plus
  • Natural Product Like Compound Library
  • Drug Repurposing Compound Library Plus
  • FDA-Approved Drug Library Plus
  • FDA-Approved Drug Library Mini
  • Bioactive Compound Library Plus
  • Anti-Infection Compound Library
  • FDA-Approved Drug Library
  • Anti-Cancer Compound Library
  • Antiviral Compound Library
  • Drug Repurposing Compound Library
  • Covalent Screening Library
  • Nucleotide Compound Library
  • Anti-COVID-19 Compound Library
  • FDA Approved & Pharmacopeial Drug Library
  • Rare Diseases Drug Library

生物活性

Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster.

体外研究
(In Vitro)

Brivudine is an analog of thymidine, and is incorporated into the viral DNA. It blocks the action of DNA polymerases, thus inhibiting viral replication. It has a stronger antiviral effect against the varicella-zoster virus compared with reference compounds such as aciclovir or penciclovir[1]. It has high, selective activity against varicella zoster virus (VZV), inhibiting VZV replication, possibly through competitive inhibition of viral DNA polymerase, or by acting as an alternative substrate to deoxythymidine triphosphate, causing viral DNA strand breakage[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究
(In Vivo)

At a dose of 125 mg once daily, brivudine has proved to be superior to aciclovir with respect to reducing the period of new blister production, and has shortened the duration of post-herpetic neuralgia[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial

分子量

333.14

Formula

C11H13BrN2O5
CAS 号

69304-47-8
中文名称

溴比夫定；溴夫定
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
In Vitro: 

DMSO : ≥ 330 mg/mL (990.57 mM)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.0017 mL 15.0087 mL 30.0174 mL
5 mM 0.6003 mL 3.0017 mL 6.0035 mL
10 mM 0.3002 mL 1.5009 mL 3.0017 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
参考文献

  • [1]. Rabasseda X, et al. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. Drugs Today (Barc). 2003 May;39(5):359-71.

    [2]. Keam SJ, et al. Brivudin (bromovinyl deoxyuridine). Drugs. 2004;64(18):2091-7; discussion 2098-9.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务